142 related articles for article (PubMed ID: 9885589)
1. Prevalence and importance of small hepatic lesions found at CT in patients with cancer.
Schwartz LH; Gandras EJ; Colangelo SM; Ercolani MC; Panicek DM
Radiology; 1999 Jan; 210(1):71-4. PubMed ID: 9885589
[TBL] [Abstract][Full Text] [Related]
2. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer.
Khalil HI; Patterson SA; Panicek DM
Radiology; 2005 Jun; 235(3):872-8. PubMed ID: 15833992
[TBL] [Abstract][Full Text] [Related]
3. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer.
Krakora GA; Coakley FV; Williams G; Yeh BM; Breiman RS; Qayyum A
Radiology; 2004 Dec; 233(3):667-73. PubMed ID: 15516602
[TBL] [Abstract][Full Text] [Related]
4. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT.
Jones EC; Chezmar JL; Nelson RC; Bernardino ME
AJR Am J Roentgenol; 1992 Mar; 158(3):535-9. PubMed ID: 1738990
[TBL] [Abstract][Full Text] [Related]
5. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.
Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP
AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040
[TBL] [Abstract][Full Text] [Related]
6. MRI evaluation of small hepatic lesions in women with breast cancer.
Patterson SA; Khalil HI; Panicek DM
AJR Am J Roentgenol; 2006 Aug; 187(2):307-12. PubMed ID: 16861531
[TBL] [Abstract][Full Text] [Related]
7. Supplement value of magnetic resonance imaging in small hepatic lesion (< or = 20 mm) detected on routine computed tomography.
Phongkitkarun S; Srianujata T; Jatchavala J
J Med Assoc Thai; 2009 May; 92(5):677-86. PubMed ID: 19459531
[TBL] [Abstract][Full Text] [Related]
8. Natural history of small, "indeterminate" hepatic lesions in patients with colorectal cancer.
Lim GH; Koh DC; Cheong WK; Wong KS; Tsang CB
Dis Colon Rectum; 2009 Aug; 52(8):1487-91. PubMed ID: 19617765
[TBL] [Abstract][Full Text] [Related]
9. Recurrent tumor after resection of hepatic metastases from colorectal carcinoma: location and time of discovery as determined by CT.
Harned RK; Chezmar JL; Nelson RC
AJR Am J Roentgenol; 1994 Jul; 163(1):93-7. PubMed ID: 8010256
[TBL] [Abstract][Full Text] [Related]
10. The mistaken or indeterminate CT diagnosis of hepatic metastases: the value of sonography.
Brick SH; Hill MC; Lande IM
AJR Am J Roentgenol; 1987 Apr; 148(4):723-6. PubMed ID: 3548284
[TBL] [Abstract][Full Text] [Related]
11. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma.
Feinstein EG; Marr BP; Winston CB; Abramson DH
Arch Ophthalmol; 2010 Mar; 128(3):319-23. PubMed ID: 20212202
[TBL] [Abstract][Full Text] [Related]
12. Detecting hepatic lesions: the added utility of CT liver window settings.
Mayo-Smith WW; Gupta H; Ridlen MS; Brody JM; Clements NC; Cronan JJ
Radiology; 1999 Mar; 210(3):601-4. PubMed ID: 10207455
[TBL] [Abstract][Full Text] [Related]
13. Detection of liver metastases from pancreatic cancer using FDG PET.
Fröhlich A; Diederichs CG; Staib L; Vogel J; Beger HG; Reske SN
J Nucl Med; 1999 Feb; 40(2):250-5. PubMed ID: 10025831
[TBL] [Abstract][Full Text] [Related]
14. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
[TBL] [Abstract][Full Text] [Related]
15. CT of hypervascular hepatic tumors: are unenhanced scans necessary for diagnosis?
Patten RM; Byun JY; Freeny PC
AJR Am J Roentgenol; 1993 Nov; 161(5):979-84. PubMed ID: 8273641
[TBL] [Abstract][Full Text] [Related]
16. Should indeterminate lung lesions reported on staging CT scans influence the management of patients with colorectal cancer?
Brent A; Talbot R; Coyne J; Nash G
Colorectal Dis; 2007 Nov; 9(9):816-8. PubMed ID: 17931171
[TBL] [Abstract][Full Text] [Related]
17. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.
Leslie DF; Johnson CD; MacCarty RL; Ward EM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Dec; 165(6):1403-6. PubMed ID: 7484574
[TBL] [Abstract][Full Text] [Related]
18. CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure.
Zacharia TT; Saini S; Halpern EF; Sumner JE
AJR Am J Roentgenol; 2006 Apr; 186(4):1067-70. PubMed ID: 16554580
[TBL] [Abstract][Full Text] [Related]
19. Is capsular retraction a specific CT sign of malignant liver tumor?
Sans N; Fajadet P; Galy-Fourcade D; Trocart J; Jarlaud T; Chiavassa H; Giron J; Railhac JJ
Eur Radiol; 1999; 9(8):1543-5. PubMed ID: 10525861
[TBL] [Abstract][Full Text] [Related]
20. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.
Kuszyk BS; Bluemke DA; Urban BA; Choti MA; Hruban RH; Sitzmann JV; Fishman EK
AJR Am J Roentgenol; 1996 Jan; 166(1):91-5. PubMed ID: 8571914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
